Ponatinib LuciPona 45 mg Tablets in London – Global Export of CML and ALL Targeted Therapy
Ponatinib LuciPona 45 mg Tablets is prescribed for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), particularly in patients with T315I mutation. Keshavdas And Sons Med Exports, operating from Nagpur, Maharashtra, offers secure international supply of LuciPona 45 mg to cancer treatment providers and licensed importers.
With verified Indian manufacturing partners, we offer bulk availability and prompt shipping, including cold-chain handling when required.
Product specs available at www.onlineglobalpharmacy.com
Enquire now for global bulk pricing and delivery support for LuciPona 45 mg Tablets.